asepticSU™ single use technology eliminates cleaning validation
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
List view / Grid view
News
New Watson-Marlow 530 pumps deliver step-change improvements in validated process security for biopharm applications
27 April 2016 | By Watson-Marlow Fluid Technology Group
Watson-Marlow Fluid Technology Group has introduced its new 530 peristaltic cased pump for upstream and downstream bioprocessing tasks...
Teaching machines to make clinical trials more successful
27 April 2016 | By Victoria White, Digital Content Producer
Researchers at are using so-called "machine learning" technologies to predict whether patients will participate in clinical trials...
NICE recommends heart failure drug Entresto
27 April 2016 | By Victoria White, Digital Content Producer
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.
EC grants marketing authorisation to Lonsurf in mCRC
27 April 2016 | By Victoria White, Digital Content Producer
The decision from the EC was based on data from the international, double-blind, placebo-controlled Phase III RECOURSE study...
NICE says ‘yes’ to two ovarian cancer drugs, rejects three
27 April 2016 | By Victoria White, Digital Content Producer
The guidance recommends paclitaxel and PLDH for treating ovarian cancer that has returned after previous chemotherapy treatment...
The global cost of norovirus
26 April 2016 | By Victoria White, Digital Content Producer
Norovirus results in roughly $4.2 billion in health care costs and $60.3 billion in societal costs annually, a new study has found...
Promising top-line results for AZP-531 in Prader-Willi Syndrome
26 April 2016 | By Victoria White, Digital Content Producer
Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)...
EC grants marketing authorisation to Lilly’s ixekizumab
26 April 2016 | By Victoria White, Digital Content Producer
The EC has granted marketing authorisation for Lilly’s ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults...
AstraZeneca and Ironwood sign Zurampic licensing agreement
26 April 2016 | By Victoria White, Digital Content Producer
Under the terms of the agreement, Ironwood Pharmaceuticals will acquire exclusive US rights to Zurampic from AstraZeneca...
Allergan’s $200 million expansion of its Waco facility gets underway
26 April 2016 | By Victoria White, Digital Content Producer
Allergan has broken ground on a $200 million expansion of its Texas Waco facility that will nearly double its current footprint when completed...
Optimising quality and production with Russell Finex sanitary screener
When Enzymatic Therapy stopped outsourcing and built its own FDA-approved manufacturing facility, the goal was to improve product quality, streamline production, and ramp up sales growth. A crucial step was selecting the right pharmaceutical sieving equipment to remove any agglomerates, oversize particles or contaminants from incoming raw dry materials.
FDA grants Breakthrough Therapy Designation to Opdivo in SCCHN
25 April 2016 | By Victoria White, Digital Content Producer
The designation is based on results of a Phase III trial evaluating Opdivo versus investigator’s choice of therapy in patients with SCCHN...
EC grants marketing authorisation for two doses of Gilead’s Descovy
25 April 2016 | By Victoria White, Digital Content Producer
Descovy is the first new HIV backbone approved in Europe in more than a decade and represents an important advance in addressing the needs of patients...
The fight against counterfeit medicines
25 April 2016 | By Victoria White, Digital Content Producer
New research is providing the foundation to apply criminology theory to preventing the production and sale of counterfeit medicines...
